is tirzepatide or semaglutide stronger Zepbound vs Wegovy: vs Weight Loss Tirzepatide vs semaglutide which is

Adverse events in relation to GLP-1R agonists for the treatment of obesity are mainly gastrointestinal side effects, including nausea, diarrhoea, vomiting and constipation, which is consistent with observations in type 2 diabetes, and rates of discontinuation due to adverse events are generally higher with GLP-1R agonists treatment compared with placebo [26, 30,31,32,33,34,35,36,37,38,39]

Retrieved 4 October 2025

You may also take your multivitamin supplement at bedtime

Since GLP-1s work best when taken consistently, having less wiggle room with a pill if you miss a dose may be a problem

Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors that remains unauthorised by the MHRA and EMA

This can lead to underreporting, making it difficult to understand how widespread this side effect might be among semaglutide users